Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults

Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)

NCT01215175 ·Status: COMPLETED ·Phase: PHASE1

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

NCT04875533 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

NCT05489328 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

NCT04278248 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents

NCT06838000 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants

NCT03512288 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

NCT00427895 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients

NCT04875858 ·Status: UNKNOWN ·Phase: PHASE4

Post-marketing Safety Evaluation of Pneumococcal Vaccines Among Children and Elderly Adults.

NCT04551248 ·Status: UNKNOWN

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

NCT06183216 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants

NCT03467984 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers

NCT04357522 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

NCT03313050 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine

NCT04989465 ·Status: COMPLETED ·Phase: PHASE4

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

NCT06151288 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults

NCT00197821 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About How a New Pneumococcal Vaccine Works in Children

NCT06531538 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and Elderly

NCT02451969 ·Status: COMPLETED ·Phase: PHASE3

Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine

NCT05731115 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

NCT00761631 ·Status: COMPLETED ·Phase: PHASE3

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

NCT03835975 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)

NCT00546572 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

NCT00744263 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety Study of NBP606 in Healthy Infants

NCT02201030 ·Status: COMPLETED ·Phase: PHASE3

Prevenar13 Post Market Surveillance

NCT01509105 ·Status: COMPLETED